Strong consensus – “point of use solution” needed
Up to 47% of the world’s population have inadequate access to diagnostics. According to “The Lancet Global Health”, in some cases only 7 – 75% have access to malaria diagnostics.
Initial estimates show that 1 million deaths could be avoided annually if the gaps in diagnostics were closed by only 10%.
The market for “in vitro diagnostics” (IVD) is growing steadily as new technologies come to market, and the clinical utility of the diagnostics has been proven
In the future, the ICHORscope device with its FMB® method will be of particular importance, as it is equal to or even significantly better than other techniques at providing molecular evidence. What makes this unique is that the speed and reliability of analysis and the digital processing of the data promise a breakthrough as a point of care solution.
In addition, relevant professional societies are calling for test capacities to be increased, reliability to be improved and access to test systems to be ensured for the population. The consensus of leading scientists and WHO calls for access to diagnostics to prevent morbidity and mortality.